Recent studies have reported that JNK/SAPK are involved and activated in response to oxidative stress-induced insults [48] in numerous human diseases, including chronic inflammation, birth defects, cancer, ischemia/reperfusion injury, and neurodegeneration, particularly Parkinson’s disease and Alzheimer’s disease [49]. This evidence concerns the gene MAPK9 and early-onset autosomal dominant Alzheimer disease.